# Dexamethasone in Herpes Simplex Virus Encephalitis

> **NCT03084783** · PHASE3 · UNKNOWN · sponsor: **University Hospital, Grenoble** · enrollment: 30 (estimated)

## Conditions studied

- HSV Encephalitis

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03084783
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-01
- **Primary completion:** 2020-11-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2020-09-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03084783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03084783, "Dexamethasone in Herpes Simplex Virus Encephalitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03084783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*